Publication

Video

Supplements and Featured Publications

Glaucoma 360: Highlights from 2020
Volume

Glaucoma 360: Lowering IOP using the MIMS solution

Author(s):

Alex Delaney-Gesing
Conferences|GLAUCOMA 360

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma called MIMS — Minimally Invasive Micro Sclerostomy — solution, designed to create a single-patient-use sterile tool and a multi-use external machine, during the 2020 Glaucoma 360 meeting in San Francisco, California.

See more Glaucoma 360 coverage here

Download Issue PDF
Articles in this issue
assessing glaucoma angle
Assessing the angle: Getting back to basics
glaucoma monitoring
OCTA: The jury is still out
funding glaucoma innovation
Funding new technologies for glaucoma treatment
glaucoma drug-delivery future
Glaucoma drug delivery devices enter new frontier
glaucoma device future
Glaucoma devices: Now and in the future
Nir Israeli, CEO and co-founder of Sanoculis
Glaucoma 360: Lowering IOP using the MIMS solution

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
Related Content
Cynthia Steel, PhD, MBA, appointed as Chief Scientific Officer of The Glaucoma Research Foundation
August 14th 2025

Cynthia Steel, PhD, MBA, appointed as Chief Scientific Officer of The Glaucoma Research Foundation

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 14th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Image credit: AdobeStock/ipopba) Robotic precision: Elevating the state of laser cataract surgery
August 14th 2025

Robotic precision: Elevating the state of laser cataract surgery

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
August 14th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

(Image credit: AdobeStock/NicoElNino) Dialing in precision: Astigmatism management with arcuate incisions
August 14th 2025

Dialing in precision: Astigmatism management with arcuate incisions

First FDA-approved treatment for MacTel performed
August 14th 2025

First FDA-approved treatment for MacTel performed

© 2025 MJH Life Sciences

All rights reserved.